FMX Stock Analysis: Fomento Economico Mexicano | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 44.237m USD | 12M Return: 47.8% | US3444191064 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 92.3M
EPS Trend: -2.7%
Qual. Beats: 0
Rev. Trend: -91.1%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fomento Económico Mexicano (FEMSA), traded on the NYSE under the ticker FMX, is a Mexican multinational founded in 1890 and headquartered in Monterrey, Mexico. It operates as a major franchise bottler of Coca-Cola trademark beverages across Latin America, producing, marketing, and distributing brands in countries including Mexico, Guatemala, Colombia, Brazil, and Argentina. The company is organized into segments such as Coca-Cola FEMSA, Proximity Americas, Proximity Europe, and Health, among others.
Beyond beverages, FEMSA runs a large small-box retail chain under the OXXO brand in Mexico, Colombia, Peru, Chile, Brazil, and the United States, along with OXXO GAS service stations in Mexico. It also operates drugstores in Chile, Colombia, Ecuador, and Mexico under brands such as Cruz Verde and Fybeca, while its European proximity division manages small-box retail and foodvenience concepts like k kiosk, BackWerk, and avec in Switzerland, Germany, Austria, Luxembourg, and the Netherlands. Additional businesses include fuel retail, transport logistics, electronic payment processing for small and medium-sized businesses (Spin), and the Bara discount grocery banner. As a constituent of the GICS Consumer Staples sector, FEMSAs operations span bottling, convenience retail, fuel, and pharmacy verticals.
- OXXO same-store sales and store count expansion lift Mexico revenue
- Mexican peso weakness pressures USD-translated bottling margins
- Coca-Cola FEMSA Latin America pricing offsets volume softness
| Net Income: 2.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.27 > 1.0 |
| NWC/Revenue: 3.82% < 20% (prev 9.72%; Δ -5.90% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.94b > Net Income 2.01b |
| Net Debt (236b) to EBITDA (27.2b): 8.71 < 3 |
| Current Ratio: 1.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (341.3m) vs 12m ago 1.86% < -2% |
| Gross Margin: 40.47% > 18% (prev 41.09%; Δ -0.62% > 0.5%) |
| Asset Turnover: 114.5% > 50% (prev 96.09%; Δ 18.46% > 0%) |
| Interest Coverage Ratio: 22.37 > 6 (EBIT TTM 24.8b / Interest Expense TTM 1.11b) |
| A: 0.04 (Total Current Assets 14.7b - Total Current Liabilities 12.8b) / Total Assets 44.4b |
| B: 0.35 (Retained Earnings 15.5b / Total Assets 44.4b) |
| C: 0.56 (EBIT TTM 24.8b / Avg Total Assets 44.3b) |
| D: 0.45 (Book Value of Equity 12.4b / Total Liabilities 27.4b) |
| Altman-Z'' = 5.66 = AAA |
| DSRI: 0.49 (Receivables 2.39b/4.05b, Revenue 50.7b/42.3b) |
| GMI: 1.02 (GM 41.09% / 40.47%) |
| AQI: 1.05 (AQ_t 0.30 / AQ_t-1 0.28) |
| SGI: 1.20 (Revenue 50.7b / 42.3b) |
| TATA: -0.04 (NI 2.01b - CFO 3.94b) / TA 44.4b) |
| Beneish M = -3.26 (Cap -4..+1) = AA |
As of November 10, 2026, the stock is trading at USD 131.27 with a total of 993,640 shares traded. Over the past week, the price has changed by +3.20%, over one month by +11.73%, over three months by +11.10% and over the past year by +47.78%.
Current recommended Stop Loss: 127.10 (which is 3.2% or 1.3 ATR below the current price).
Fomento Economico Mexicano has received a consensus analysts rating of 3.80. Therefore, it is recommended to hold FMX.
- StrongBuy: 5
- Buy: 3
- Hold: 6
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 134.9 | 2.7% |
Market Cap MXN = 820b (44.2b USD * 18.5257 USD.MXN)
P/E Trailing = 8.4045
P/E Forward = 89.2857
P/S = 0.0494
P/B = 3.6338
P/EG = 4.7275
Revenue TTM = 50.7b MXN
EBIT TTM = 24.8b MXN
EBITDA TTM = 27.2b MXN
Long Term Debt = 126b MXN (from longTermDebt, last quarter)
Short Term Debt = 1.64b MXN (from shortTermDebt, last quarter)
Debt = 243b MXN (corrected: LT Debt 126b + ST Debt 1.64b) + Leases 115b
Net Debt = 236b MXN (calculated: Debt 243b - CCE 6.43b)
Enterprise Value = 1056b MXN (820b + Debt 243b - CCE 6.43b)
Interest Coverage Ratio = 22.37 (Ebit TTM 24.8b / Interest Expense TTM 1.11b)
EV/FCF = 655.7x (Enterprise Value 1056b / FCF TTM 1.61b)
FCF Yield = 0.15% (FCF TTM 1.61b / Enterprise Value 1056b)
FCF Margin = 3.18% (FCF TTM 1.61b / Revenue TTM 50.7b)
Net Margin = 3.97% (Net Income TTM 2.01b / Revenue TTM 50.7b)
Gross Margin = 40.47% ((Revenue TTM 50.7b - Cost of Revenue TTM 30.2b) / Revenue TTM)
Gross Margin QoQ = 39.92% (prev 40.09%)
Tobins Q-Ratio = 23.76 (Enterprise Value 1056b / Total Assets 44.4b)
Interest Expense / Debt = 0.46% (Interest Expense 1.11b / Debt 243b)
Taxrate = 30.14% (1.17b / 3.87b)
NOPAT = 17.3b (EBIT 24.8b * (1 - 30.14%))
Current Ratio = 1.15 (Total Current Assets 14.7b / Total Current Liabilities 12.8b)
Debt / Equity = 19.52 (Debt 243b / totalStockholderEquity, last quarter 12.4b)
Debt / EBITDA = 8.71 (Net Debt 236b / EBITDA 27.2b)
Debt / FCF = 146.8 (Net Debt 236b / FCF TTM 1.61b)
Total Stockholder Equity = 12.6b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.55% (Net Income 2.01b / Total Assets 44.4b)
RoE = 16.02% (Net Income TTM 2.01b / Total Stockholder Equity 12.6b)
RoCE = 17.83% (EBIT 24.8b / Capital Employed (Equity 12.6b + L.T.Debt 126b))
RoIC = 56.33% (NOPAT 17.3b / Invested Capital 30.8b)
WACC = 5.28% (E(820b)/V(1062b) * Re(6.75%) + D(243b)/V(1062b) * Rd(0.46%) * (1-Tc(0.30)))
Discount Rate = 6.75% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -79.74 | Cagr: -51.72%
[DCF] Terminal Value 77.97% ; FCFF base≈1.38b ; Y1≈1.58b ; Y5≈2.33b
[DCF] Fair Price = N/A (negative equity: EV 35.1b - Net Debt 236b = -201b; debt exceeds intrinsic value)
EPS Correlation: -2.74 | EPS CAGR: -0.97% | SUE: -0.02 | # QB: 0
Revenue Correlation: -91.13 | Revenue CAGR: -73.60% | SUE: -0.67 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.89 | Chg30d=-10.10% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=5.63 | Chg30d=+1.15% | Revisions=-17% | GrowthEPS=+97.1% | GrowthRev=+7.4%
EPS next Year (2027-12-31): EPS=5.15 | Chg30d=-2.01% | Revisions=-29% | GrowthEPS=-8.6% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -36% (up=2, down=6)